Sort
50,496 grants matching “lung cancer”
Point-of care Microfluidics for Early Detection of Cancer
$2,082,080Mehmet Toner · Massachusetts General Hospital · U01 · FY2016 · EB
Point-of care Microfluidics for Early Detection of Cancer
$2,082,080Mehmet Toner · Massachusetts General Hospital · U01 · FY2018 · EB
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$2,082,030Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Clinical Validation Center for Lung Cancer Early Detection
$2,077,743Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology
$2,076,805Dennis E. Discher · University Of Pennsylvania · U54 · FY2017 · CA
Infections, immunity, and inflammation in cancer
$2,075,667Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$2,073,213Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Cellular and Molecular Mechanisms of Lung Disease
$2,072,821Bruce A. Stanton · Dartmouth College · P20 · FY2011 · RR
Growth Factor Imaging and Photoimmunotherapy
$2,071,751Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$2,070,907Lisa Rider · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Cellular and Molecular Mechanisms of Lung Disease
$2,070,856Bruce A. Stanton · Dartmouth College · P20 · FY2012 · GM
Infections, immunity, and inflammation in cancer
$2,070,679Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Melanoma and Skin Cancer Program SPORE
$2,070,180Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,069,846Roy S Herbst · Yale University · P50 · FY2023 · CA
Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors
$2,069,712Siddarth Selvaraj · Arima Genomics, Inc. · R44 · FY2023 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,069,565Steven Mark Albelda · University Of Pennsylvania · P01 · FY2019 · CA
Administrative Core A
$2,069,128Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Molecular Diagnostics Core Laboratory
$2,068,937Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Center for Cell-based Therapy - Cures
$2,065,053Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK
$2,065,030Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
The Co-Clinical Project: Informing clinical trials using preclinical mouse models
$2,064,367Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · RC2 · FY2009 · CA
Brain Tumor Clinical and Clinical Research Program
$2,062,121Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2019 · CA
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$2,061,095Sanku Mallik · North Dakota State University · P20 · FY2016 · GM
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma
$2,060,104Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2009 · HL
Identifying Metabolic Vulnerabilities in Lung Cancer
$2,060,040Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2021 · CA